Skip to main content

Rheumatoid Arthritis

      RT @ejdein1: Abst#1462 shows coal mining and non-coal silica exposure with increased risk of RA with OR ~4. Great study,
      4 years ago
      Abst#1462 shows coal mining and non-coal silica exposure with increased risk of RA with OR ~4. Great study, not a surprise that toxin exposures linked to autoimmunity. #ACR20 @RheumNow. https://t.co/OnwVUfoRCU
      RT @RichardPAConway: Dr Trupin presents further data on link between silica exposure and coal mining in particular with
      Dr Trupin presents further data on link between silica exposure and coal mining in particular with development of incident RA. Duration and intensity of exposure both associated with increased risk. @rheumnow #ACR20 Abstr#1462 https://t.co/5SpqElhlZN
      RT @drdavidliew: Can hs-troponin and hsCRP predict future major cardiovascular events? Certainly appears so in RA pts (n
      4 years ago
      Can hs-troponin and hsCRP predict future major cardiovascular events? Certainly appears so in RA pts (n=636). To what extent do subclinical dx and inflammation combine to cause future RA CV pain? PRECISION trial subgroup @ElaineHusniMD @DanielHSolomon #ACR20 ABST1189 @RheumNow https://t.co/ZYTpodatVI
      Potpourri of Pathotypes of Predictors with RA Faculty

      Dr. Jonathan Kay again leads an international panel of rheumatologists to elicit their opinions on key abstracts at ACR 2020. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks.

      RT @drdavidliew: The lung-joint axis in RA just keeps on getting stronger

      Lung ACPA present in early untreated RA/CSA:
      4 years ago
      The lung-joint axis in RA just keeps on getting stronger Lung ACPA present in early untreated RA/CSA: crossreact acetylated/carbamylated antigens differ in effects on cell types (neut activation, fibroblasts, osteoclasts) Isn't lung ACPA fascinating? #ACR20 ABST1445 @RheumNow https://t.co/9VKSRYlndT
      Study of 351 SLE patients from Leiden shows that SLE with Neuropsychatric disease do not have a higher mortality than lu
      4 years ago
      Study of 351 SLE patients from Leiden shows that SLE with Neuropsychatric disease do not have a higher mortality than lupus without CNS disease; but do have higher mortality than gen. population #ACR20 Abstr#1264 https://t.co/CmBjfUj1Ur https://t.co/WYZQDaI4yt
      RT @Janetbirdope: Who will clot in #Lupus? 150 with SLE, clots ^ if PC4d + = market of plt Activation & arterial thr
      4 years ago
      Who will clot in #Lupus? 150 with SLE, clots ^ if PC4d + = market of plt Activation & arterial thrombosis abstr#1510 needs validation in another SLE group. V interesting @RheumNow @CRASCRRheum #ACR20 https://t.co/UBGxaFwhwZ
      RT @KDAO2011: ACR/AF JIA guidelines presented @ACR20:
      👉Initiate DMARD early over NSAID monotherapy
      👉Use SQ MTX&gt
      4 years ago
      ACR/AF JIA guidelines presented @ACR20: 👉Initiate DMARD early over NSAID monotherapy 👉Use SQ MTX> oral MTX > SSZ/LEF 👉add biologic preferred over triple DMARD 👉DON'T use chronic low dose steroids 👉combo biologic+DMARD > biologic monoRx https://t.co/lwoFSTuV91 @rheumnow https://t.co/wzh2LCS0dN
      Risk of Skin Cancer with Methotrexate: Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1001 presented at the 2020 ACR annual meeting.

      Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein

      Dr. Eric Dein reviews abstract #0483 presented Friday at the ACR annual meeting.